|
Psychiatric
disorders are more common among smokers than in the general population.
Smokers with psychiatric disorders should be provided with smoking
cessation counseling and pharmacotherapy if necessary.
Bupropion is
effective in treating depression and should especially be considered
for smokers with a current or previous depressive disorder. In addition,
smoking cessation interventions do not interfere with recovery from
dependency on other drugs.
Quitting smoking
may affect the pharmacokinetics of certain psychiatric medications,
so you need to monitor the actions or side effects of these drugs
in smokers who are attempting to quit.
|